Black Friday Savings ! Exclusive Deals on Latest Pharma and Medical Technology Reports.

Explore Now

Sturge Weber Syndrome Sws Epidemiology Forecast

DelveInsight's "Sturge-weber Syndrome (SWS) - Epidemiology Forecast to 2030" report delivers an in-depth understanding of the disease, historical and forecasted Sturge-weber Syndrome (SWS) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Geographies Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2018-2030

Sturge-weber Syndrome (SWS) Understanding

The DelveInsight Sturge-weber Syndrome (SWS) epidemiology report gives a thorough understanding of the Sturge-weber Syndrome (SWS) by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Sturge-weber Syndrome (SWS) in the US, Europe, and Japan. The report covers the detailed information of the Sturge-weber Syndrome (SWS) epidemiology scenario in seven major countries (US, EU5, and Japan).

Sturge-weber Syndrome (SWS) Epidemiology Perspective by DelveInsight

The Sturge-weber Syndrome (SWS) epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Sturge-weber Syndrome (SWS) epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Sturge-weber Syndrome (SWS) epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2018 to 2030. It also helps recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Sturge-weber Syndrome (SWS) Detailed Epidemiology Segmentation

The Sturge-weber Syndrome (SWS) epidemiology covered in the report provides historical as well as forecasted Sturge-weber Syndrome (SWS) epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2018 to 2030.


The DelveInsight Sturge-weber Syndrome (SWS) report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

Scope of the Report

  • The Sturge-weber Syndrome (SWS) report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The Sturge-weber Syndrome (SWS) Epidemiology Report and Model provide an overview of the global trends of Sturge-weber Syndrome (SWS) in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
  • The report provides insight into the historical and forecasted patient pool of Sturge-weber Syndrome (SWS) in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  • The report helps recognize the growth opportunities in the 7MM for the patient population
  • The report assesses the disease risk and burden and highlights the unmet needs of Sturge-weber Syndrome (SWS)
  • The report provides the segmentation of the Sturge-weber Syndrome (SWS) epidemiology

Report Highlights

  • 11-year Forecast of Sturge-weber Syndrome (SWS) epidemiology
  • 7MM Coverage
  • Prevalent and Diagnosed Cases of Sturge-weber Syndrome (SWS)
  • Cases of Sturge-weber Syndrome (SWS) by Mutation Types
  • Sturge-weber Syndrome (SWS) Cases associated with Clinical Manifestations

KOL views

We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

  • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Sturge-weber Syndrome (SWS)?
  • What are the key findings pertaining to the Sturge-weber Syndrome (SWS) epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2018-2030)?
  • What would be the total number of patients of Sturge-weber Syndrome (SWS) across the 7MM during the forecast period (2018-2030)?
  • Among the EU5 countries, which country will have the highest number of patients during the forecast period (2018-2030)?
  • At what CAGR the patient population is expected to grow in 7MM during the forecast period (2018-2030)?
  • What is the disease risk, burden and unmet needs of Sturge-weber Syndrome (SWS)?
  • What are the currently available treatments of Sturge-weber Syndrome (SWS)?

Reasons to buy

The Sturge-weber Syndrome (SWS) Epidemiology report will allow the user to -

  • Develop business strategies by understanding the trends shaping and driving the global Sturge-weber Syndrome (SWS) market
  • Quantify patient populations in the global Sturge-weber Syndrome (SWS) market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Sturge-weber Syndrome (SWS) therapeutics in each of the markets covered
  • Understand the magnitude of Sturge-weber Syndrome (SWS) population by its epidemiology
  • The Sturge-weber Syndrome (SWS) Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

Key Assessments

  • Patient Segmentation
  • Disease Risk & Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

1. Key Insights 

2. Executive Summary of Sturge-weber Syndrome (SWS)

3. Sturge-weber Syndrome (SWS): Disease Background and Overview

3.1. Introduction

3.2. Sign and Symptoms

3.3. Pathophysiology

3.4. Risk Factors

3.5. Diagnosis

4. Patient Journey

5. Epidemiology and Patient Population

5.1. Epidemiology Key Findings

5.2. Assumptions and Rationale: 7MM

5.3. Epidemiology Scenario: 7MM

5.3.1. Sturge-weber Syndrome (SWS) Epidemiology Scenario in the 7MM (2018- 2030)

5.4. United States Epidemiology

5.4.1. Sturge-weber Syndrome (SWS) Epidemiology Scenario in the United States (2018- 2030)

5.5. EU-5 Country-wise Epidemiology

5.5.1. Germany Epidemiology

5.5.1.1. Sturge-weber Syndrome (SWS) Epidemiology Scenario in Germany (2018- 2030)

5.5.2. France Epidemiology

5.5.2.1. Sturge-weber Syndrome (SWS) Epidemiology Scenario in France (2018- 2030)

5.5.3. Italy Epidemiology

5.5.3.1. Sturge-weber Syndrome (SWS) Epidemiology Scenario in Italy (2018- 2030)

5.5.4. Spain Epidemiology

5.5.4.1. Sturge-weber Syndrome (SWS) Epidemiology Scenario in Spain (2018- 2030)

5.5.5. United Kingdom Epidemiology

5.5.5.1. Sturge-weber Syndrome (SWS) Epidemiology Scenario in the United Kingdom (2018-2030)

5.6. Japan Epidemiology

5.6.1. Sturge-weber Syndrome (SWS) Epidemiology Scenario in Japan (2018- 2030)

6. Treatment Algorithm, Current Treatment, and Medical Practices

6.1. Sturge-weber Syndrome (SWS) Treatment and Management

6.2. Sturge-weber Syndrome (SWS) Treatment Algorithm

7. KOL Views

8. Unmet Needs

9.  Appendix

9.1. Bibliography

9.2. Report Methodology

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight

*The table of contents is not exhaustive; will be provided in the final report

List of Tables

Table 1:  Sturge-weber Syndrome (SWS) Epidemiology in 7MM (2018-2030)

Table 2: Sturge-weber Syndrome (SWS) Diagnosed and Treatable Cases in 7MM (2018-2030)

Table 3: Sturge-weber Syndrome (SWS) Epidemiology in the United States (2018-2030)

Table 4: Sturge-weber Syndrome (SWS) Diagnosed and Treatable Cases in the United States (2018-2030)

Table 5: Sturge-weber Syndrome (SWS) Epidemiology in Germany (2018-2030)

Table 6: Sturge-weber Syndrome (SWS) Diagnosed and Treatable Cases in Germany (2018-2030)

Table 7: Sturge-weber Syndrome (SWS) Epidemiology in France (2018-2030)

Table 8: Sturge-weber Syndrome (SWS) Diagnosed and Treatable Cases in France (2018-2030)

Table 9: Sturge-weber Syndrome (SWS) Epidemiology in Italy (2018-2030)

Table 10: Sturge-weber Syndrome (SWS) Diagnosed and Treatable Cases in Italy (2018-2030)

Table 11: Sturge-weber Syndrome (SWS) Epidemiology in Spain (2018-2030)

Table 12: Sturge-weber Syndrome (SWS) Diagnosed and Treatable Cases in Spain (2018-2030)

Table 13: Sturge-weber Syndrome (SWS) Epidemiology in the United Kingdom (2018-2030)

Table 14: Sturge-weber Syndrome (SWS) Diagnosed and Treatable Cases in the United Kingdom (2018-2030)

Table 15: Sturge-weber Syndrome (SWS) Epidemiology in Japan (2018-2030)

Table 16: Sturge-weber Syndrome (SWS) Diagnosed and Treatable Cases in Japan (2018-2030)

List of Figures

Figure 1 Sturge-weber Syndrome (SWS) Epidemiology in 7MM (2018-2030)

Figure 2 Sturge-weber Syndrome (SWS) Diagnosed and Treatable Cases in 7MM (2018-2030)

Figure 3 Sturge-weber Syndrome (SWS) Epidemiology in the United States (2018-2030)

Figure 4 Sturge-weber Syndrome (SWS) Diagnosed and Treatable Cases in the United States (2018-2030)

Figure 5  Sturge-weber Syndrome (SWS) Epidemiology in Germany (2018-2030)

Figure 6  Sturge-weber Syndrome (SWS) Diagnosed and Treatable Cases in Germany (2018-2030)

Figure 7  Sturge-weber Syndrome (SWS) Epidemiology in France (2018-2030)

Figure 8 Sturge-weber Syndrome (SWS) Diagnosed and Treatable Cases in France (2018-2030)

Figure 9 Sturge-weber Syndrome (SWS) Epidemiology in Italy (2018-2030)

Figure 10 Sturge-weber Syndrome (SWS) Diagnosed and Treatable Cases in Italy (2018-2030)

Figure 11 Sturge-weber Syndrome (SWS) Epidemiology in Spain (2018-2030)

Figure 12 Sturge-weber Syndrome (SWS) Diagnosed and Treatable Cases in Spain (2018-2030)

Figure 13 Sturge-weber Syndrome (SWS) Epidemiology in the United Kingdom (2018-2030)

Figure 14 Sturge-weber Syndrome (SWS) Diagnosed and Treatable Cases in the United Kingdom (2018-2030)

Figure 15 Sturge-weber Syndrome (SWS) Epidemiology in Japan (2018-2030)

Figure 16 Sturge-weber Syndrome (SWS) Diagnosed and Treatable Cases in Japan (2018-2030)

*The table of contents is not exhaustive; will be provided in the final report


Forward to Friend

Need A Quote